2-38068389-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_000104.4(CYP1B1):c.*2333G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00175 in 227,722 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0024 ( 3 hom., cov: 33)
Exomes 𝑓: 0.00038 ( 0 hom. )
Consequence
CYP1B1
NM_000104.4 3_prime_UTR
NM_000104.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.45
Publications
0 publications found
Genes affected
CYP1B1 (HGNC:2597): (cytochrome P450 family 1 subfamily B member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008]
CYP1B1 Gene-Disease associations (from GenCC):
- CYP1B1-related glaucoma with or without anterior segment dysgenesisInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics
- glaucoma 3AInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, G2P
- anterior segment dysgenesis 6Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
- congenital glaucomaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Peters anomalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BS2
High Homozygotes in GnomAd4 at 3 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYP1B1 | NM_000104.4 | c.*2333G>A | 3_prime_UTR_variant | Exon 3 of 3 | ENST00000610745.5 | NP_000095.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYP1B1 | ENST00000610745.5 | c.*2333G>A | 3_prime_UTR_variant | Exon 3 of 3 | 1 | NM_000104.4 | ENSP00000478561.1 | |||
CYP1B1 | ENST00000490576.2 | c.*2333G>A | 3_prime_UTR_variant | Exon 3 of 3 | 4 | ENSP00000478839.2 | ||||
CYP1B1 | ENST00000714520.1 | c.*2333G>A | 3_prime_UTR_variant | Exon 3 of 3 | ENSP00000519767.1 | |||||
CYP1B1 | ENST00000491456.1 | n.184+789G>A | intron_variant | Intron 2 of 2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00240 AC: 365AN: 152186Hom.: 2 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
365
AN:
152186
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000385 AC: 29AN: 75418Hom.: 0 Cov.: 0 AF XY: 0.000201 AC XY: 7AN XY: 34882 show subpopulations
GnomAD4 exome
AF:
AC:
29
AN:
75418
Hom.:
Cov.:
0
AF XY:
AC XY:
7
AN XY:
34882
show subpopulations
African (AFR)
AF:
AC:
25
AN:
3522
American (AMR)
AF:
AC:
1
AN:
2286
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
4798
East Asian (EAS)
AF:
AC:
0
AN:
10792
South Asian (SAS)
AF:
AC:
0
AN:
648
European-Finnish (FIN)
AF:
AC:
0
AN:
194
Middle Eastern (MID)
AF:
AC:
1
AN:
462
European-Non Finnish (NFE)
AF:
AC:
0
AN:
46366
Other (OTH)
AF:
AC:
2
AN:
6350
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.523
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00242 AC: 369AN: 152304Hom.: 3 Cov.: 33 AF XY: 0.00219 AC XY: 163AN XY: 74474 show subpopulations
GnomAD4 genome
AF:
AC:
369
AN:
152304
Hom.:
Cov.:
33
AF XY:
AC XY:
163
AN XY:
74474
show subpopulations
African (AFR)
AF:
AC:
361
AN:
41554
American (AMR)
AF:
AC:
3
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5194
South Asian (SAS)
AF:
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2
AN:
68034
Other (OTH)
AF:
AC:
3
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
17
34
50
67
84
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
5
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Irido-corneo-trabecular dysgenesis Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Primary congenital glaucoma Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.